SCHEMBL6165826

SCHEMBL6165826

Cn1nc(C2CC2)c2c1CCCC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
CSNK2A1 P68400 2/20 0.40
PLK1 P53350 1/20 0.40
PLK3 Q9H4B4 1/20 0.40
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
SRC P12931 2/20 0.35
OPRM1 P35372 2/20 0.34
HTR1A P08908 2/20 0.34
DRD2 P14416 2/20 0.34
HTR2A P28223 2/20 0.34
ELANE P08246 1/20 0.32
TSHR P16473 2/20 0.31
LMNA P02545 1/20 0.31
BUB1 O43683 1/20 0.30
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30
NTRK2 Q16620 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168258 0.78 HTT (0.65) HTTCSNK2A1PLK1PLK3ELANE
SCHEMBL6166081 0.75 BRD4 (0.34) CSNK2A1OPRM1BUB1CSNK2A2CSNK2B
SCHEMBL6164696 0.75 HTT (0.61) HTTCSNK2A1PLK1PLK3ALDH1A1
SCHEMBL6166825 0.74 OPRM1 (0.54) HTTOPRM1LMNA
SCHEMBL6166055 0.74 ALDH1A1 (0.46) HTTCSNK2A1ALDH1A1KDM4EPKM
SCHEMBL6772956 0.72 SRC (0.49) HTTCSNK2A1ALDH1A1KDM4EPKM
SCHEMBL6770960 0.72 SRC (0.43) HTTCSNK2A1ALDH1A1KDM4EPKM
SCHEMBL6771178 0.72 SRC (0.43) HTTCSNK2A1ALDH1A1KDM4EPKM
SCHEMBL6164352 0.72 DHODH (0.34) OPRM1
SCHEMBL6166619 0.71 HTT (0.42) HTTCSNK2A1PLK1PLK3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed